Demand For Surgical Heart Valves Projected To Slowly Decline
The market for surgical heart valve replacement devices is projected to steadily decline, as newer, more innovative transcatheter techniques poach customers, according to a new report from Informa’s Meddevicetracker.
You may also be interested in...
The US FDA approved Abbott’s new Epic Plus stented tissue mitral valve and Epic Plus Supra stented tissue aortic valve.
Results showed that patients were less likely to exhibit disease progression, or die, following treatment with beta-emitted microspheres.
A pilot study of the augmented reality system suggests it improves the precision of knee arthroplasty surgery.